2
Participants
Start Date
April 30, 2012
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
Verapamil
"Verapamil will be prepared as a solution. A 50mg/ml oral suspension may be made with immediate release tablets and either a 1:1 mixture of Ora-Sweet and Ora-Plus or a 1:1 mixture of Ora-Sweet SF and Ora-Plus will be used.~Children will start on a 4 weeks titration period:~Week 1: 1mg/kg/day divided BID Week 2: 2mg/kg/day divided BID or TID Week 3: 3mg/kg/day divided BID or TID Week 4: 4mg/kg/day divided TID~In event of adverse events, and in consultation with the family and treating physician, the dosage may be decreased to 2mg/kg/day and remain at that dose for the remainder of the study."
Gillette Children's Specialty Healthcare, Saint Paul
Mayo Clinic, Rochester
Children's Memorial Hospital, Chicago
Mary Hitchcock Memorial Hospital, Lebanon
Collaborators (1)
Mayo Clinic
OTHER
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
Gillette Children's Specialty Healthcare
OTHER